+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report by Component, by Modality (VA, VV, AV) by Patient Type, by Application, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 110 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 4778237
The global extracorporeal membrane oxygenation machine market size is expected to reach USD 445.7 million by 2030., registering a CAGR of 5.3% during the forecast period. The market is primarily driven by the increasing incidence of cardiopulmonary & respiratory diseases and technological advancements in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.



According to the WHO, 17.9 million people died from cardiovascular diseases in 2019 In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures coupled with various government initiatives is further propelling the growth.

The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth. Applications of ECMO machine procedures have increased over the years. ECMO machine was traditionally used in cases of circulatory or respiratory failure, its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.

The ECMO machine use has been rising gradually worldwide, owing to its benefits such as artificial lungs for the patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is also aiding in the growth of the market. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011.

Extracorporeal Membrane Oxygenation Machine Market Report Highlights

  • North America accounted for the largest share in 2021 owing to favorable reimbursement policies, the presence of key players, and government initiatives .
  • by component, the oxygenators segment accounted for the largest market size owing to its high cost and usage .
  • by modality, the veno-arterial segment accounted for the largest market size and is also expected to grow at the fastest rate during the forecast period .
  • by patient type, the adult segment is growing at a rapid pace during the forecast period owing to the rising incidence of cardiac and pulmonary diseases .
  • by application, the respiratory segment held the largest market size in 2021 and is also expected to grow at the fastest rate .
  • Major players in the market are focusing on technological collaboration and product launches .


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Extracorporeal Membrane Oxygenation Machine Market

What is the estimated value of the Global Extracorporeal Membrane Oxygenation Machine Market?

The Global Extracorporeal Membrane Oxygenation Machine Market was estimated to be valued at $294.2 Million in 2022.

What is the growth rate of the Global Extracorporeal Membrane Oxygenation Machine Market?

The growth rate of the Global Extracorporeal Membrane Oxygenation Machine Market is 5.3%, with an estimated value of $445.7 Million by 2030.

What is the forecasted size of the Global Extracorporeal Membrane Oxygenation Machine Market?

The Global Extracorporeal Membrane Oxygenation Machine Market is estimated to be worth $445.7 Million by 2030.

Who are the key companies in the Global Extracorporeal Membrane Oxygenation Machine Market?

Key companies in the Global Extracorporeal Membrane Oxygenation Machine Market include Medtronic Plc, Maquet Holding, Microport Scientific Corporation, Terumo Cardiovascular System Corporation, Medos Medizintechnik, Nipro Medical Corporation, LivaNova PLC and EUROSETS S.R.L.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. Modality
1.1.3. Patient Type
1.1.4. by Application
1.1.5. Country scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component outlook
2.2.2. Modality outlook
2.2.3. Patient type outlook
2.2.4. Application outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. ECMO Machine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of cardiopulmonary and respiratory diseases
3.4.1.2. Increasing adoption of ECMO machines in hospitals
3.4.1.3. Technological advancement in ECMO machines
3.4.1.4. Growing awareness towards the application of ECMO
3.4.2. Market restraint analysis
3.4.2.1. High cost of procedures
3.4.2.2. Risk of complications during ECMO procedures
3.4.2.3. Presence of conventional technique
3.4.3. Industry challenges
3.5. ECMO Machine Market Analysis Tools
3.5.1. Industry Analysis-Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. ECMO Machine Market: Component Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Pumps
4.1.2. Oxygenator
4.1.3. Controllers
4.1.4. Cannula
4.1.5. Accessories
4.2. Product Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global ECMO Machine Market by Component Outlook
4.4.1. Pumps
4.4.1.1. Pump market estimates and forecast, 2018-2030 (USD Million)
4.4.2. Oxygenator
4.4.2.1. Oxygenator market estimates and forecast, 2018-2030 (USD Million)
4.4.3. Controllers
4.4.3.1. Controllers market estimates and forecast, 2018-2030 (USD Million)
4.4.4. Cannula
4.4.4.1. Cannula market estimates and forecast, 2018-2030 (USD Million)
4.4.5. Accessories
4.4.5.1. Accessories market estimates and forecast, 2018-2030 (USD Million)
Chapter 5. ECMO Machine Market: Modality Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Veno-Arterial
5.1.2. Veno-Venous
5.1.3. Arterio-Venous
5.2. by Modality Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global ECMO Machine Market by Modality Outlook
5.4.1. Veno-Arterial
5.4.1.1. Veno-Arterial market estimates and forecast, 2018-2030 (USD Million)
5.4.2. Veno-Venous
5.4.2.1. Veno-Venous market estimates and forecast, 2018-2030 (USD Million)
5.4.3. Arterio-Venous
5.4.3.1. Arterio-Venous market estimates and forecast, 2018-2030 (USD Million)
Chapter 6. ECMO Machine Market: Patient Type Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Neonates
6.1.2. Pediatric
6.1.3. Adult
6.2. Patient Type Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global ECMO machine market by Patient Type Outlook
6.4.1. Neonates
6.4.1.1. Neonates market estimates and forecast, 2018-2030 (USD Million)
6.4.2. Pediatric
6.4.2.1. Pediatric market estimates and forecast, 2018-2030 (USD Million)
6.4.3. Adult
6.4.3.1. Adult market estimates and forecast, 2018-2030 (USD Million)
Chapter 7. ECMO machine Market: Application Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Respiratory
7.1.2. Cardiac
7.1.3. ECPR
7.2. Application Market Share, 2021 & 2030
7.3. Segment Dashboard
7.4. Global ECMO machine Market by application Outlook
7.4.1. Respiratory
7.4.1.1. Respiratory market estimates and forecast, 2018-2030 (USD Million)
7.4.1.2. Respiratory market estimates and forecast, by patient type, 2018-2030 (USD Million)
7.4.1.2.1. Neonates
7.4.1.2.2. Pediatric
7.4.1.2.3. Adult
7.4.2. Cardiac
7.4.2.1. Cardiac market estimates and forecast, 2018-2030 (USD Million)
7.4.2.2. Cardiac market estimates and forecast, by patient type, 2018-2030 (USD Million)
7.4.2.2.1. Neonates
7.4.2.2.2. Pediatric
7.4.2.2.3. Adult
7.4.3. ECPR
7.4.3.1. ECPR market estimates and forecast, 2018-2030 (USD Million)
7.4.3.2. ECPR market estimates and forecast, by patient type, 2018-2030 (USD Million)
7.4.3.2.1. Neonates
7.4.3.2.2. Pediatric
7.4.3.2.3. Adult
Chapter 8. ECMO Machine Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2021 & 2030
8.2. Regional Market Dashboard
8.3. Regional Market Snapshot
8.4. Regional Market Share and Leading Players, 2021
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Latin America
8.4.5. Middle East and Africa
8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1. North America
8.5.2. Europe
8.5.3. Asia Pacific
8.5.4. Latin America
8.5.5. Middle East and Africa
8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
8.7. North America
8.7.1. Market estimates and forecast, 2018-2030 (USD Million)
8.7.2. U.S.
8.7.2.1. U.S. market estimates and forecast, 2018-2030 (USD Million)
8.7.3. Canada
8.7.3.1. Canada market estimates and forecast, 2018-2030 (USD Million)
8.8. Europe
8.8.1. Market estimates and forecast, 2018-2030 (USD Million)
8.8.2. U.K.
8.8.2.1. U.K. market estimates and forecast, 2018-2030 (USD Million)
8.8.3. Germany
8.8.3.1. Germany market estimates and forecast, 2018-2030 (USD Million)
8.8.4. France
8.8.4.1. France market estimates and forecast, 2018-2030 (USD Million)
8.8.5. Italy
8.8.5.1. Italy market estimates and forecast, 2018-2030 (USD Million)
8.8.6. Spain
8.8.6.1. Spain market estimates and forecast, 2018-2030 (USD Million)
8.8.7. Czech Republic
8.8.7.1. Czech Republic market estimates and forecast, 2018-2030 (USD Million)
8.8.8. Russia
8.8.8.1. Russia market estimates and forecast, 2018-2030 (USD Million)
8.8.9. Poland
8.8.9.1. Poland market estimates and forecast, 2018-2030 (USD Million)
8.8.10. Turkey
8.8.10.1. Turkey market estimates and forecast, 2018-2030 (USD Million)
8.8.11. Switzerland
8.8.11.1. Switzerland market estimates and forecast, 2018-2030 (USD Million)
8.9. Asia Pacific
8.9.1. Market estimates and forecast, 2018-2030 (USD Million)
8.9.2. Japan
8.9.2.1. Japan market estimates and forecast, 2018-2030 (USD Million)
8.9.3. China
8.9.3.1. China market estimates and forecast, 2018-2030 (USD Million)
8.9.4. India
8.9.4.1. India market estimates and forecast, 2018-2030 (USD Million)
8.9.5. Australia
8.9.5.1. Australia market estimates and forecast, 2018-2030 (USD Million)
8.9.6. South Korea
8.9.6.1. South Korea market estimates and forecast, 2018-2030 (USD Million)
8.9.7. Vietnam
8.9.7.1. Vietnam market estimates and forecast, 2018-2030 (USD Million)
8.9.8. Philippines
8.9.8.1. Philippines market estimates and forecast, 2018-2030 (USD Million)
8.9.9. Malaysia
8.9.9.1. Malaysia market estimates and forecast, 2018-2030 (USD Million)
8.9.10. Indonesia
8.9.10.1. Indonesia market estimates and forecast, 2018-2030 (USD Million)
8.9.11. Thailand
8.9.11.1. Thailand market estimates and forecast, 2018-2030 (USD Million)
8.10. Latin America
8.10.1. Market estimates and forecast, 2018-2030 (USD Million)
8.10.2. Brazil
8.10.2.1. Brazil market estimates and forecast, 2018-2030 (USD Million)
8.10.3. Mexico
8.10.3.1. Mexico market estimates and forecast, 2018-2030 (USD Million)
8.10.4. Colombia
8.10.4.1. Colombia market estimates and forecast, 2018-2030 (USD Million)
8.10.5. Argentina
8.10.5.1. Argentina market estimates and forecast, 2018-2030 (USD Million)
8.10.6. Chile
8.10.6.1. Chile market estimates and forecast, 2018-2030 (USD Million)
8.11. Middle East & Africa
8.11.1. Market estimates and forecast, 2018-2030 (USD Million)
8.11.2. South Africa
8.11.2.1. South Africa market estimates and forecast, 2018-2030 (USD Million)
8.11.3. Saudi Arabia
8.11.3.1. Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
8.11.4. UAE
8.11.4.1. UAE market estimates and forecast, 2018-2030 (USD Million)
8.11.5. Oman
8.11.5.1. Oman market estimates and forecast, 2018-2030 (USD Million)
8.11.6. Kuwait
8.11.6.1. Kuwait market estimates and forecast, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2021
9.3.4. Medtronic Plc
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Procedure benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Maquet Holding
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Procedure benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Microport Scientific Corporation
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Procedure benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Terumo Cardiovascular System Corporation
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Procedure benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Medos Medizintechnik
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Procedure benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Nipro Medical Corporation
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Procedure benchmarking
9.3.9.4. Strategic initiatives
9.3.10. LivaNova PLC
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Procedure benchmarking
9.3.10.4. Strategic initiatives
9.3.11. CytoSorbents Corporation
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Procedure benchmarking
9.3.11.4. Strategic initiatives
9.3.12. EUROSETS S.R.L
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Procedure benchmarking
9.3.12.4. Strategic initiatives

Companies Mentioned

  • Medtronic Plc
  • Maquet Holding
  • Microport Scientific Corporation
  • Terumo Cardiovascular System Corporation
  • Medos Medizintechnik
  • Nipro Medical Corporation
  • LivaNova PLC
  • CytoSorbents Corporation
  • EUROSETS S.R.L

Methodology

Loading
LOADING...